Shares of INVO Bioscience, Inc. INVO rose sharply in today’s pre-market trading after reporting fourth-quarter results. The company said quarterly revenue surged 397% year-over-year to $1,381,754, ...
Post-merger, the combined company, operating under the name "NAYA Biosciences", will be dedicated to increasing patient access to life-transforming treatments in oncology, fertility, and regenerative ...
SARASOTA, Fla. and MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience (INVO) today announced it has closed its merger with NAYA Biosciences, a company dedicated to increasing patient access to ...
・Last month, INVO Fertility signed a definitive agreement to acquire Family Beginnings, a fertility clinic. ・INVO Fertility also announced a private placement worth $4 million last month. ・Terah ...
INVO Fertility reported Q1 2025 revenue growth but significant net losses, primarily due to impairment charges related to NAYA Therapeutics. INVO Fertility, Inc. recently reported its financial ...
INVO Fertility, Inc. announced a 1-for-3 reverse stock split of its common stock effective July 21, 2025, in order to comply with Nasdaq's minimum bid price requirement of $1.00 per share. After the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results